GLP-1 medicines
Where to inject Zepbound
Three body areas, one of which you cannot reach yourself. Everything below is from the prescribing information, not from a forum.
The three places
The label is short about this, and one detail in it gets missed:
Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm. Rotate injection sites with each dose.
So: the abdomen and the thigh you can do yourself. The back of the upper arm is for someone else to do. That is not fussiness about technique — you cannot see or reach the back of your own arm well enough to control the angle, and the tissue there is thinner.
- 1Abdomen. You can do it yourself. Stay a couple of inches away from the navel.
- 2Thigh. You can do it yourself.
- 3Back of the upper arm. Only when another person gives the injection.
What rotating actually means
"Rotate injection sites with each dose" does not mean alternating between two spots. It means not putting this week's injection where last week's went.
Injection site reactions appear on the label in 6–8% of people depending on the dose, against 2% on placebo. Using the same square inch every week is the avoidable part of that number.
A simple rotation that works: left side of the abdomen, right side of the abdomen, left thigh, right thigh, then back round. Stay a couple of inches away from the navel.
Timing
Administer ZEPBOUND once weekly at any time of day, with or without meals.
There is no best hour, and no requirement to eat first. Pick a day you will remember. The only thing worth being consistent about is the day of the week, because that is what the dose schedule is built on.
If you miss one
If a dose is missed, instruct patients to administer ZEPBOUND as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day.
Four days is the whole rule. Inside it, take the dose. Outside it, skip it.
Never share a pen
Never share ZEPBOUND KwikPen between patients, even if the pen needle is changed.
Changing the needle does not make a pen safe to pass on. Blood can enter the cartridge. This is the same warning that sits on insulin pens, for the same reason.
What this page cannot tell you
Whether Zepbound is right for you, which dose, or how to handle a side effect you are actually having. Those need a clinician with your history in front of them. MED Miami does not offer that yet.
Where this came from
- FDA, Highlights of Prescribing Information: ZEPBOUND (tirzepatide) injection, 2025 revision — accessdata.fda.gov
- openFDA drug label API, ZEPBOUND record, retrieved 23 September 2026 — api.fda.gov